Nikhil Lalwani - Nov 26, 2024 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
PRESIDENT & CEO, Director
Signature
/s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Nov 26, 2024
Transactions value $
-$1,941,442
Form type
4
Date filed
11/27/2024, 05:38 PM
Previous filing
Sep 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Options Exercise $870K +30K +8.02% $29.00 404K Nov 26, 2024 Direct
transaction ANIP Common Stock Sale -$1.74M -30K -7.43% $57.95 374K Nov 26, 2024 Direct F1
transaction ANIP Common Stock Sale -$203K -3.48K -0.93% $58.30 370K Nov 26, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIP Stock Option (right to buy) Options Exercise -$870K -30K -17.85% $29.00 138K Nov 26, 2024 Common Stock 30K $29.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold in multiple trades at prices ranging from $57.76 to $58.55. The price reported above reflects the weighted average sales price.
F2 The shares were sold in multiple trades at prices ranging from $58.18 to $58.61. The price reported above reflects the weighted average sales price.
F3 25% of the total options vested on each of September 8, 2021, September 8, 2022, September 8, 2023 and September 8, 2024.